LAVA Therapeutics N.V.

NASDAQ: LVTX · Real-Time Price · USD
1.53
0.01 (0.66%)
At close: Aug 18, 2025, 10:49 AM

LAVA Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
35.02M 44.23M 100.33M 151.01M
Short-Term Investments
41.56M 51.34M 32.53M 47.99M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
91K 319K 809K 902.43K
Receivables
n/a 1.7M 3.25M 734K
Inventory
n/a n/a n/a -48.83M
Other Current Assets
1.65M 1.63M n/a n/a
Total Current Assets
79.3M 98.9M 140.53M 154.76M
Property-Plant & Equipment
1.44M 2.49M 2.08M 2.21M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.53M 2.81M 2.89M 3.11M
Total Assets
80.83M 101.71M 143.43M 157.87M
Account Payables
2.72M 4.45M 3.96M 2.55M
Deferred Revenue
35M n/a 35M 1.73M
Short-Term Debt
4.89M 5.28M 4.64M n/a
Other Current Liabilities
1.26M 482K 11.07M 6.75M
Total Current Liabilities
18.01M 14.94M 21.95M 5.02M
Long-Term Debt
80K n/a n/a 4.28M
Other Long-Term Liabilities
35M n/a n/a 5.03M
Total Long-Term Liabilities
35.08M 35.59M 35.43M 18.65M
Total Liabilities
53.09M 50.53M 57.38M 23.67M
Total Debt
5.28M 6.31M 5.45M 5.52M
Common Stock
3.72M 3.71M 3.71M 4.14M
Retained Earnings
-174.97M -148.07M -108.07M -89.26M
Comprehensive Income
-12.65M -10.9M -4.03M 1.33M
Shareholders Equity
27.75M 51.18M 86.04M 134.19M
Total Investments
41.56M 51.34M 32.53M 47.99M